The report "Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027", size is projected to reach USD 229.9 billion by 2027 from USD 99.9 billion in 2021, at a CAGR of 14.9% during the forecast period.
Browse 280 market data Tables and 47 Figures spread through 325 Pages and in-depth TOC on "Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-market-890.html
The increasing demand for pharmaceutical packaging in emerging markets owing to growing consumer awareness regarding healthier lifestyle, better access to healthcare, rising healthcare expenses, and growth of the aging population. Also, advanced drug delivery and innovative packaging solutions with higher patient convenience and compliance drive the market for pharmaceutical packaging. Increasing occurrence of chronic diseases such as cancer, infectious diseases, and others and rising patient friendly packaging are also expected to drive the market for pharmaceutical packaging during the forecast period.
Based on raw material, plastics is projected to register the highest CAGR during the forecast period.
Plastics is projected to register the highest CAGR between 2022 and 2027. Plastics &polymers are widely used as raw materials for pharmaceutical packaging. Plastic provides freedom of design and cost-effective solution, making it a highly compatible solution for pharmaceutical packaging. Plastic is used widely in rigid pharmaceutical packaging for manufacturing various types of packaging such as bottles, jars, caps & closures. The exceptional shatter resistance provided by plastics enables ease of handling and transportation. In addition, plastics can be attributed to their easy moldability, strength, and effective barrier against gas and vapor.
Based on type, Prefilled syringes is projected to register the highest CAGR during the forecast period.
Prefilled syringes provide advantages such as minimal drug wastage, increased product lifespan, enhanced protection, ease of use, reliable, sterility, self-medication features, and others. Prefilled syringes are rapidly replacing vials and traditional syringes. Growing elderly population suffering from chronic diseases such as diabetes, cancer, Parkinson’s, needing regular treatment via dosing is one of the key drivers for this market.
Based on drug delivery, Injectable delivery is projected to register the highest CAGR during the forecast period.
Injectable delivery segment is the fastest growing market during the forecast period. Injectables are available as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and others. Prefilled syringes are the most adopted method of injectable drug delivery The advantages of injectable packaging are improved patient compliance, prolonged steady state drug plasma concentration, maximum drug utilization, reduced dosing frequency, self-injection option, and reduced cost of therapy.
Based on region, North America is estimated to be the largest market share for pharmaceutical packaging in 2022
North America is estimated to be the largest market share for pharmaceutical packaging in 2022. The rapid evolving pharmaceutical therapies, new pharmaceutical drug innovation and growing demand for smart packaging from pharmaceutical industries are driving the pharmaceutical packaging market in the region. The growing demand from the aging people, increase in chronic diseases such as diabetes, and commercialization of pharmaceuticals with huge government investment are also one of the major driving factors for the market.
The key players in the pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US). These players have established a strong foothold in the market by adopting strategies, such as new product launches, investment & expansions, agreements, partnerships, and mergers & acquisitions.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441